Explore more publications!

Reunion Business Network Press Releases

Labels On
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
Info
Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates
EU Balance of Payments and International Investment Position statistical sources and methods - B.o.p. and i.i.p. e-book

EU Balance of Payments and International Investment Position statistical sources and methods - B.o.p. and i.i.p. e-book

Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities
World Chase Tag® Doubles Global Quad™ Presence, Signaling Worldwide Expansion
Valneva Responds to French Government’s Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion
Ethanol Market Worth USD 163.9 Billion by 2032 at 4.9% CAGR
Convening of the Annual General Meeting to approve the 2023 financial statements to be held on January 31, 2025 and evolution of the Atos Board of Directors
OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance -  Publication of Circular for Combined Annual General Meeting of  September 30, 2025
Statement on the Cabinet meeting of Wednesday, 17 September 2025

Statement on the Cabinet meeting of Wednesday, 17 September 2025

Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.
Bloomin' Blinds of BuxMont Is 2025 Franchise Owner of the Year at National Awards Event
WHO cautions against increase of chikungunya illness

WHO cautions against increase of chikungunya illness

Deputy President Shipokosa Paulus Mashatile: Heritage Day 2025

Deputy President Shipokosa Paulus Mashatile: Heritage Day 2025

Combined General Meeting of June 11, 2025
Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States
Public Health Action Network Is A Partnering Organization for the  'Healthy Indoor Air' Event at the UN General Assembly
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information
Combined General Meeting of June 13, 2025
WHO cautions of increase of chikungunya disease

WHO cautions of increase of chikungunya disease

COMBINED SHAREHOLDERS’ MEETING TO BE HELD ON TUESDAY 29 APRIL 2025: AVAILABILITY OF THE DOCUMENTS

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions